RECRUITING

Resilient Together for Dementia (RT-D)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will evaluate the feasibility and preliminary efficacy of the novel Resilient Together for Dementia (RT-D) intervention for couples following dementia diagnoses. The primary target is emotional distress, and the program aims to prevent chronic distress in at-risk couples.

Official Title

Resilient Together for Dementia: a Live Video Resiliency Dyadic Intervention for Persons with Dementia and Their Care-partners Early After Diagnosis

Quick Facts

Study Start:2025-02-19
Study Completion:2027-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06619327

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Recent (\~3 month) chart documented ADRD diagnosis,
  2. * ADRD symptom onset after age 65
  3. * Cognitive assessment scores and symptoms consistent with early stage dementia, as determined by the Clinical Dementia Rating Scale scores of .5 or 1.0
  4. * Cognitive awareness of their problems (as determined by the treating neurologist), and ability to understand study and research protocol, as determined by a standardized teach-back method assessment
  5. * English speaking adults (18 years or older)
  6. * Dyad lives together
  7. * At least one partner endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression scale subscales or \<5 on the Geriatric Depression Scale)
  1. * Patient is deemed inappropriate by the neurology team
  2. * Either partner has a co-occurring terminal illness
  3. * Patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team.

Contacts and Locations

Study Contact

Sarah M. Bannon, PhD
CONTACT
212-241-0787
sarah.bannon@mountsinai.org
Sydney M, McCage
CONTACT
212-241-6866
sydney.mccage@mountsinai.org

Principal Investigator

Sarah Bannon, PhD
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Brain Injury Research Center at Mount Sinai
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Sarah Bannon, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-19
Study Completion Date2027-06-30

Study Record Updates

Study Start Date2025-02-19
Study Completion Date2027-06-30

Terms related to this study

Keywords Provided by Researchers

  • Dementia
  • Care partners
  • Dyads
  • Emotional distress
  • Quality of life
  • Couples

Additional Relevant MeSH Terms

  • Dementia